SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0000920465-19-000067
Filing Date
2019-04-30
Accepted
2019-04-30 16:27:47
Documents
4
Period of Report
2018-12-31

Document Format Files

Seq Description Document Type Size
1 10-K/A a201810-ka.htm 10-K/A 428226
2 EXHIBIT 31.1 exhibit311-10ka2018.htm EX-31.1 14169
3 EXHIBIT 31.2 exhibit312-10ka2018.htm EX-31.2 14808
4 EXHIBIT 32.1 exhibit321-10ka2018.htm EX-32.1 11753
  Complete submission text file 0000920465-19-000067.txt   469964
Mailing Address 4550 TOWNE CENTRE COURT SAN DIEGO CA 92121
Business Address 4550 TOWNE CENTRE COURT SAN DIEGO CA 92121 858-207-4264
LA JOLLA PHARMACEUTICAL CO (Filer) CIK: 0000920465 (see all company filings)

IRS No.: 330361285 | State of Incorp.: CA | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-36282 | Film No.: 19782171
SIC: 2836 Biological Products, (No Diagnostic Substances)